1. Home
  2. MERC vs LXRX Comparison

MERC vs LXRX Comparison

Compare MERC & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MERC
  • LXRX
  • Stock Information
  • Founded
  • MERC 1968
  • LXRX 1995
  • Country
  • MERC Canada
  • LXRX United States
  • Employees
  • MERC N/A
  • LXRX N/A
  • Industry
  • MERC Paper
  • LXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MERC Basic Materials
  • LXRX Health Care
  • Exchange
  • MERC Nasdaq
  • LXRX Nasdaq
  • Market Cap
  • MERC 271.5M
  • LXRX 228.8M
  • IPO Year
  • MERC 1987
  • LXRX 2000
  • Fundamental
  • Price
  • MERC $3.58
  • LXRX $0.63
  • Analyst Decision
  • MERC Hold
  • LXRX Buy
  • Analyst Count
  • MERC 3
  • LXRX 4
  • Target Price
  • MERC $5.33
  • LXRX $3.67
  • AVG Volume (30 Days)
  • MERC 707.8K
  • LXRX 4.1M
  • Earning Date
  • MERC 05-01-2025
  • LXRX 05-13-2025
  • Dividend Yield
  • MERC 8.37%
  • LXRX N/A
  • EPS Growth
  • MERC N/A
  • LXRX N/A
  • EPS
  • MERC N/A
  • LXRX N/A
  • Revenue
  • MERC $1,996,904,000.00
  • LXRX $31,213,000.00
  • Revenue This Year
  • MERC $2.43
  • LXRX N/A
  • Revenue Next Year
  • MERC $6.12
  • LXRX $46.60
  • P/E Ratio
  • MERC N/A
  • LXRX N/A
  • Revenue Growth
  • MERC N/A
  • LXRX 1251.21
  • 52 Week Low
  • MERC $3.20
  • LXRX $0.28
  • 52 Week High
  • MERC $9.78
  • LXRX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • MERC 34.30
  • LXRX 50.34
  • Support Level
  • MERC $3.47
  • LXRX $0.52
  • Resistance Level
  • MERC $4.22
  • LXRX $0.72
  • Average True Range (ATR)
  • MERC 0.17
  • LXRX 0.05
  • MACD
  • MERC 0.03
  • LXRX 0.00
  • Stochastic Oscillator
  • MERC 14.67
  • LXRX 55.52

About MERC Mercer International Inc.

Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: